GAD antibody-associated neurological illness and its relationship to gluten sensitivity

Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. 
Acta Neurol Scand: 2011: 123: 175–180.
© 2010 The Authors Journal compilation © 2010 Blackwell Munksgaard. Background –  The h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta neurologica Scandinavica 2011-03, Vol.123 (3), p.175-180
Hauptverfasser: Hadjivassiliou, M., Aeschlimann, D., Grünewald, R. A., Sanders, D. S., Sharrack, B., Woodroofe, N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 180
container_issue 3
container_start_page 175
container_title Acta neurologica Scandinavica
container_volume 123
creator Hadjivassiliou, M.
Aeschlimann, D.
Grünewald, R. A.
Sanders, D. S.
Sharrack, B.
Woodroofe, N.
description Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. 
Acta Neurol Scand: 2011: 123: 175–180.
© 2010 The Authors Journal compilation © 2010 Blackwell Munksgaard. Background –  The high prevalence of gluten sensitivity in patients with stiff‐person syndrome (SPS) lead us to investigate the relationship between gluten sensitivity and GAD‐antibody‐associated diseases. Methods –  We used ELISA assays for anti‐GAD and for serological markers of gluten sensitivity. Patients were recruited from clinics based at the Royal Hallamshire hospital, Sheffield, UK. Patients with gluten sensitivity were followed up after the introduction of a gluten‐free diet and serological testing was repeated. Results –  Six of seven (86%) patients with SPS were positive for anti‐GAD, mean titre 109 U/ml; This compared with 9/90 (11%) patients with idiopathic sporadic ataxia, mean titre 32 U/ml, 16/40 (40%) patients with gluten ataxia, mean titre 25 U/ml, and 6/10 patients with type 1 diabetes only, mean titre 8 U/ml. None of 32 patients with celiac disease only, and of 40 patients with genetic ataxia were positive for anti‐GAD. The titre of anti‐GAD reduced following the introduction of a gluten‐free diet in patients with SPS who had serological evidence of gluten sensitivity. The same was observed in patients with gluten ataxia and anti‐GAD antibodies. This was also associated with clinical improvement. Conclusion –  These findings suggest a link between gluten sensitivity and GAD antibody‐associated diseases.
doi_str_mv 10.1111/j.1600-0404.2010.01356.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_879474362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>879474362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5356-dd35363c247bdbbd6574d21f1c799e58ddccb2d009e8d7ff4a3ac4544e6654003</originalsourceid><addsrcrecordid>eNqFkUtvEzEURi1ERdPCX0DeIFYT_PbMgkXUR0CKUqkKisTG8tie4uDMhLEHkn-Pp0nDEm_8uOezrXsAgBhNcR6fNlMsECoQQ2xKUD5FmHIx3b8Ck3PhNZgghHAhKGaX4CrGTd4RydgbcEkQ44IwPgHr-ewW6jb5urOHQsfYGa-Ts7B1Q9-F7skbHaAPoXUxZtBCnyLsXdDJd2384XcwdfApDMm1MLo2-uR_-3R4Cy4aHaJ7d5qvwbf7u9XNl2LxMP96M1sUhucfF9ZSTgU1hMna1rUVXDJLcIONrCrHS2uNqYlFqHKllU3DNNWGccacEJwhRK_Bx-O9u777NbiY1NZH40LQreuGqEpZMcmoIP8nWUkxqUiVyfcncqi3zqpd77e6P6iXrmXgwwnQMben6XVrfPzH0ZIR8fzk5yP3xwd3ONcxUqNFtVGjLDXKUqNF9WxR7dVseTeucr445n1Mbn_O6_6nEpJKrtbLuVrJx2rxfbVUa_oXNKGfQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>848312929</pqid></control><display><type>article</type><title>GAD antibody-associated neurological illness and its relationship to gluten sensitivity</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hadjivassiliou, M. ; Aeschlimann, D. ; Grünewald, R. A. ; Sanders, D. S. ; Sharrack, B. ; Woodroofe, N.</creator><creatorcontrib>Hadjivassiliou, M. ; Aeschlimann, D. ; Grünewald, R. A. ; Sanders, D. S. ; Sharrack, B. ; Woodroofe, N.</creatorcontrib><description>Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. 
Acta Neurol Scand: 2011: 123: 175–180.
© 2010 The Authors Journal compilation © 2010 Blackwell Munksgaard. Background –  The high prevalence of gluten sensitivity in patients with stiff‐person syndrome (SPS) lead us to investigate the relationship between gluten sensitivity and GAD‐antibody‐associated diseases. Methods –  We used ELISA assays for anti‐GAD and for serological markers of gluten sensitivity. Patients were recruited from clinics based at the Royal Hallamshire hospital, Sheffield, UK. Patients with gluten sensitivity were followed up after the introduction of a gluten‐free diet and serological testing was repeated. Results –  Six of seven (86%) patients with SPS were positive for anti‐GAD, mean titre 109 U/ml; This compared with 9/90 (11%) patients with idiopathic sporadic ataxia, mean titre 32 U/ml, 16/40 (40%) patients with gluten ataxia, mean titre 25 U/ml, and 6/10 patients with type 1 diabetes only, mean titre 8 U/ml. None of 32 patients with celiac disease only, and of 40 patients with genetic ataxia were positive for anti‐GAD. The titre of anti‐GAD reduced following the introduction of a gluten‐free diet in patients with SPS who had serological evidence of gluten sensitivity. The same was observed in patients with gluten ataxia and anti‐GAD antibodies. This was also associated with clinical improvement. Conclusion –  These findings suggest a link between gluten sensitivity and GAD antibody‐associated diseases.</description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>DOI: 10.1111/j.1600-0404.2010.01356.x</identifier><identifier>PMID: 20456245</identifier><identifier>CODEN: ANRSAS</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; anti-GAD ; Antibodies ; Ataxia ; Autoantibodies - adverse effects ; Autoantibodies - biosynthesis ; Autoantibodies - blood ; Biological and medical sciences ; Celiac disease ; Celiac Disease - enzymology ; Celiac Disease - epidemiology ; Celiac Disease - immunology ; Comorbidity ; Diabetes mellitus ; Diets ; Enzyme-Linked Immunosorbent Assay ; Female ; Glutamate decarboxylase ; Glutamate Decarboxylase - blood ; Glutamate Decarboxylase - immunology ; Gluten ; gluten sensitivity ; gluten-free diet ; Hematologic and hematopoietic diseases ; Hospitals ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Neurology ; Prevalence ; Risk Factors ; stiff-person syndrome ; United Kingdom - epidemiology</subject><ispartof>Acta neurologica Scandinavica, 2011-03, Vol.123 (3), p.175-180</ispartof><rights>Copyright © 2010 The Authors. Journal compilation © 2010 Blackwell Munksgaard</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 The Authors. Journal compilation © 2010 Blackwell Munksgaard.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5356-dd35363c247bdbbd6574d21f1c799e58ddccb2d009e8d7ff4a3ac4544e6654003</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0404.2010.01356.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0404.2010.01356.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23842662$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20456245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hadjivassiliou, M.</creatorcontrib><creatorcontrib>Aeschlimann, D.</creatorcontrib><creatorcontrib>Grünewald, R. A.</creatorcontrib><creatorcontrib>Sanders, D. S.</creatorcontrib><creatorcontrib>Sharrack, B.</creatorcontrib><creatorcontrib>Woodroofe, N.</creatorcontrib><title>GAD antibody-associated neurological illness and its relationship to gluten sensitivity</title><title>Acta neurologica Scandinavica</title><addtitle>Acta Neurol Scand</addtitle><description>Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. 
Acta Neurol Scand: 2011: 123: 175–180.
© 2010 The Authors Journal compilation © 2010 Blackwell Munksgaard. Background –  The high prevalence of gluten sensitivity in patients with stiff‐person syndrome (SPS) lead us to investigate the relationship between gluten sensitivity and GAD‐antibody‐associated diseases. Methods –  We used ELISA assays for anti‐GAD and for serological markers of gluten sensitivity. Patients were recruited from clinics based at the Royal Hallamshire hospital, Sheffield, UK. Patients with gluten sensitivity were followed up after the introduction of a gluten‐free diet and serological testing was repeated. Results –  Six of seven (86%) patients with SPS were positive for anti‐GAD, mean titre 109 U/ml; This compared with 9/90 (11%) patients with idiopathic sporadic ataxia, mean titre 32 U/ml, 16/40 (40%) patients with gluten ataxia, mean titre 25 U/ml, and 6/10 patients with type 1 diabetes only, mean titre 8 U/ml. None of 32 patients with celiac disease only, and of 40 patients with genetic ataxia were positive for anti‐GAD. The titre of anti‐GAD reduced following the introduction of a gluten‐free diet in patients with SPS who had serological evidence of gluten sensitivity. The same was observed in patients with gluten ataxia and anti‐GAD antibodies. This was also associated with clinical improvement. Conclusion –  These findings suggest a link between gluten sensitivity and GAD antibody‐associated diseases.</description><subject>Adult</subject><subject>Aged</subject><subject>anti-GAD</subject><subject>Antibodies</subject><subject>Ataxia</subject><subject>Autoantibodies - adverse effects</subject><subject>Autoantibodies - biosynthesis</subject><subject>Autoantibodies - blood</subject><subject>Biological and medical sciences</subject><subject>Celiac disease</subject><subject>Celiac Disease - enzymology</subject><subject>Celiac Disease - epidemiology</subject><subject>Celiac Disease - immunology</subject><subject>Comorbidity</subject><subject>Diabetes mellitus</subject><subject>Diets</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Glutamate decarboxylase</subject><subject>Glutamate Decarboxylase - blood</subject><subject>Glutamate Decarboxylase - immunology</subject><subject>Gluten</subject><subject>gluten sensitivity</subject><subject>gluten-free diet</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>stiff-person syndrome</subject><subject>United Kingdom - epidemiology</subject><issn>0001-6314</issn><issn>1600-0404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtvEzEURi1ERdPCX0DeIFYT_PbMgkXUR0CKUqkKisTG8tie4uDMhLEHkn-Pp0nDEm_8uOezrXsAgBhNcR6fNlMsECoQQ2xKUD5FmHIx3b8Ck3PhNZgghHAhKGaX4CrGTd4RydgbcEkQ44IwPgHr-ewW6jb5urOHQsfYGa-Ts7B1Q9-F7skbHaAPoXUxZtBCnyLsXdDJd2384XcwdfApDMm1MLo2-uR_-3R4Cy4aHaJ7d5qvwbf7u9XNl2LxMP96M1sUhucfF9ZSTgU1hMna1rUVXDJLcIONrCrHS2uNqYlFqHKllU3DNNWGccacEJwhRK_Bx-O9u777NbiY1NZH40LQreuGqEpZMcmoIP8nWUkxqUiVyfcncqi3zqpd77e6P6iXrmXgwwnQMben6XVrfPzH0ZIR8fzk5yP3xwd3ONcxUqNFtVGjLDXKUqNF9WxR7dVseTeucr445n1Mbn_O6_6nEpJKrtbLuVrJx2rxfbVUa_oXNKGfQQ</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Hadjivassiliou, M.</creator><creator>Aeschlimann, D.</creator><creator>Grünewald, R. A.</creator><creator>Sanders, D. S.</creator><creator>Sharrack, B.</creator><creator>Woodroofe, N.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>201103</creationdate><title>GAD antibody-associated neurological illness and its relationship to gluten sensitivity</title><author>Hadjivassiliou, M. ; Aeschlimann, D. ; Grünewald, R. A. ; Sanders, D. S. ; Sharrack, B. ; Woodroofe, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5356-dd35363c247bdbbd6574d21f1c799e58ddccb2d009e8d7ff4a3ac4544e6654003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>anti-GAD</topic><topic>Antibodies</topic><topic>Ataxia</topic><topic>Autoantibodies - adverse effects</topic><topic>Autoantibodies - biosynthesis</topic><topic>Autoantibodies - blood</topic><topic>Biological and medical sciences</topic><topic>Celiac disease</topic><topic>Celiac Disease - enzymology</topic><topic>Celiac Disease - epidemiology</topic><topic>Celiac Disease - immunology</topic><topic>Comorbidity</topic><topic>Diabetes mellitus</topic><topic>Diets</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Glutamate decarboxylase</topic><topic>Glutamate Decarboxylase - blood</topic><topic>Glutamate Decarboxylase - immunology</topic><topic>Gluten</topic><topic>gluten sensitivity</topic><topic>gluten-free diet</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>stiff-person syndrome</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadjivassiliou, M.</creatorcontrib><creatorcontrib>Aeschlimann, D.</creatorcontrib><creatorcontrib>Grünewald, R. A.</creatorcontrib><creatorcontrib>Sanders, D. S.</creatorcontrib><creatorcontrib>Sharrack, B.</creatorcontrib><creatorcontrib>Woodroofe, N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadjivassiliou, M.</au><au>Aeschlimann, D.</au><au>Grünewald, R. A.</au><au>Sanders, D. S.</au><au>Sharrack, B.</au><au>Woodroofe, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GAD antibody-associated neurological illness and its relationship to gluten sensitivity</atitle><jtitle>Acta neurologica Scandinavica</jtitle><addtitle>Acta Neurol Scand</addtitle><date>2011-03</date><risdate>2011</risdate><volume>123</volume><issue>3</issue><spage>175</spage><epage>180</epage><pages>175-180</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><coden>ANRSAS</coden><abstract>Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody associated neurological illness and its relationship to gluten sensitivity. 
Acta Neurol Scand: 2011: 123: 175–180.
© 2010 The Authors Journal compilation © 2010 Blackwell Munksgaard. Background –  The high prevalence of gluten sensitivity in patients with stiff‐person syndrome (SPS) lead us to investigate the relationship between gluten sensitivity and GAD‐antibody‐associated diseases. Methods –  We used ELISA assays for anti‐GAD and for serological markers of gluten sensitivity. Patients were recruited from clinics based at the Royal Hallamshire hospital, Sheffield, UK. Patients with gluten sensitivity were followed up after the introduction of a gluten‐free diet and serological testing was repeated. Results –  Six of seven (86%) patients with SPS were positive for anti‐GAD, mean titre 109 U/ml; This compared with 9/90 (11%) patients with idiopathic sporadic ataxia, mean titre 32 U/ml, 16/40 (40%) patients with gluten ataxia, mean titre 25 U/ml, and 6/10 patients with type 1 diabetes only, mean titre 8 U/ml. None of 32 patients with celiac disease only, and of 40 patients with genetic ataxia were positive for anti‐GAD. The titre of anti‐GAD reduced following the introduction of a gluten‐free diet in patients with SPS who had serological evidence of gluten sensitivity. The same was observed in patients with gluten ataxia and anti‐GAD antibodies. This was also associated with clinical improvement. Conclusion –  These findings suggest a link between gluten sensitivity and GAD antibody‐associated diseases.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20456245</pmid><doi>10.1111/j.1600-0404.2010.01356.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6314
ispartof Acta neurologica Scandinavica, 2011-03, Vol.123 (3), p.175-180
issn 0001-6314
1600-0404
language eng
recordid cdi_proquest_miscellaneous_879474362
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
anti-GAD
Antibodies
Ataxia
Autoantibodies - adverse effects
Autoantibodies - biosynthesis
Autoantibodies - blood
Biological and medical sciences
Celiac disease
Celiac Disease - enzymology
Celiac Disease - epidemiology
Celiac Disease - immunology
Comorbidity
Diabetes mellitus
Diets
Enzyme-Linked Immunosorbent Assay
Female
Glutamate decarboxylase
Glutamate Decarboxylase - blood
Glutamate Decarboxylase - immunology
Gluten
gluten sensitivity
gluten-free diet
Hematologic and hematopoietic diseases
Hospitals
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Middle Aged
Neurology
Prevalence
Risk Factors
stiff-person syndrome
United Kingdom - epidemiology
title GAD antibody-associated neurological illness and its relationship to gluten sensitivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A58%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GAD%20antibody-associated%20neurological%20illness%20and%20its%20relationship%20to%20gluten%20sensitivity&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Hadjivassiliou,%20M.&rft.date=2011-03&rft.volume=123&rft.issue=3&rft.spage=175&rft.epage=180&rft.pages=175-180&rft.issn=0001-6314&rft.eissn=1600-0404&rft.coden=ANRSAS&rft_id=info:doi/10.1111/j.1600-0404.2010.01356.x&rft_dat=%3Cproquest_pubme%3E879474362%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=848312929&rft_id=info:pmid/20456245&rfr_iscdi=true